EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 44 filers reported holding EVELO BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 2.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $134 | -88.7% | 739 | 0.0% | 0.00% | – |
Q4 2022 | $1,190 | -40.5% | 739 | 0.0% | 0.00% | – |
Q3 2022 | $2,000 | 0.0% | 739 | 0.0% | 0.00% | – |
Q2 2022 | $2,000 | -33.3% | 739 | 0.0% | 0.00% | – |
Q1 2022 | $3,000 | -91.7% | 739 | -87.4% | 0.00% | -100.0% |
Q4 2021 | $36,000 | -82.8% | 5,879 | -80.2% | 0.01% | -85.4% |
Q3 2021 | $209,000 | -51.5% | 29,705 | -5.3% | 0.04% | -59.0% |
Q2 2021 | $431,000 | +29.0% | 31,354 | +0.3% | 0.10% | +2.0% |
Q1 2021 | $334,000 | -2.6% | 31,245 | +10.2% | 0.10% | -16.2% |
Q4 2020 | $343,000 | +190.7% | 28,353 | +26.3% | 0.12% | +143.8% |
Q3 2020 | $118,000 | +20.4% | 22,452 | +12.1% | 0.05% | +2.1% |
Q2 2020 | $98,000 | +30.7% | 20,031 | -0.1% | 0.05% | 0.0% |
Q1 2020 | $75,000 | +150.0% | 20,042 | +175.8% | 0.05% | +176.5% |
Q4 2019 | $30,000 | -31.8% | 7,268 | 0.0% | 0.02% | -41.4% |
Q3 2019 | $44,000 | -32.3% | 7,268 | 0.0% | 0.03% | -39.6% |
Q2 2019 | $65,000 | +12.1% | 7,268 | 0.0% | 0.05% | +4.3% |
Q1 2019 | $58,000 | -20.5% | 7,268 | +29.5% | 0.05% | -32.4% |
Q4 2018 | $73,000 | – | 5,613 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 50,427,328 | $105,393,000 | 4.44% |
HARBOURVEST PARTNERS LLC | 3,063,505 | $6,403,000 | 2.09% |
CVI Holdings, LLC | 1,693,655 | $3,540,000 | 0.27% |
Alphabet Inc. | 1,060,495 | $2,216,000 | 0.11% |
STATE OF MICHIGAN RETIREMENT SYSTEM | 4,070,728 | $8,508,000 | 0.06% |
CREDIT SUISSE AG/ | 3,670,178 | $7,670,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 105,300 | $220,000 | 0.01% |
FMR LLC | 16,199,055 | $33,856,000 | 0.00% |
OCCUDO QUANTITATIVE STRATEGIES LP | 25,346 | $53,000 | 0.00% |
Ergoteles LLC | 27,429 | $57,000 | 0.00% |